SS Innovations International, Inc. (SSII)

US — Healthcare Sector
Peers: PRCT  AORT  ATEC  ATRC  LFST  UFPT  NHC  ANIP  TWST  BGM 

Automate Your Wheel Strategy on SSII

With Tiblio's Option Bot, you can configure your own wheel strategy including SSII - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol SSII
  • Rev/Share 0.1248
  • Book/Share 0.2171
  • PB 42.6086
  • Debt/Equity 0.2329
  • CurrentRatio 2.5897
  • ROIC -0.3459

 

  • MktCap 1790692793.0
  • FreeCF/Share -0.0895
  • PFCF -103.3477
  • PE -91.7775
  • Debt/Assets 0.1399
  • DivYield 0
  • ROE -0.7099

 

  • Rating D+
  • Score 1
  • Recommendation Strong Sell
  • P/E Score 1
  • DCF Score 1
  • P/B Score 1
  • D/E Score 1

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
No ratings available.

News

SS Innovations to Participate in Upcoming Investor Conferences
SSII
Published: October 21, 2025 by: MCAP MediaWire
Sentiment: Neutral

Fort Lauderdale, FL, October 21, 2025 – PRISM MediaWire (Press Release Service – Press Release Distribution) – SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced that Dr.

Read More
image for news SS Innovations to Participate in Upcoming Investor Conferences
SS Innovations to Participate in Upcoming Investor Conferences
SSII
Published: October 21, 2025 by: GlobeNewsWire
Sentiment: Neutral

FORT LAUDERDALE, Fla., Oct. 21, 2025 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced that Dr. Sudhir Srivastava, Chairman of the Board and Chief Executive Officer, and Dr. Vishwa Srivastava, Chief Executive Officer – Asia Pacific, are scheduled to participate in the following upcoming investor conferences: UBS Global Healthcare Conference Palm Beach Gardens, FLTuesday, November 11, 2025Management will be available for one-on-one and small group meetings throughout the day.

Read More
image for news SS Innovations to Participate in Upcoming Investor Conferences

About SS Innovations International, Inc. (SSII)

  • IPO Date 2018-10-17
  • Website https://ssinnovations.com
  • Industry Medical - Devices
  • CEO Sudhir Prem Srivastava
  • Employees 378

SS Innovations International, Inc. develops surgical robotic systems. It also develops SSI Mantra, a surgical robotic system; SSI Mudra, a range of surgical instruments that supports in surgical procedures, including robotic cardiac surgery; SSI Maya, a robotic surgery platform; and OMNI 3D HD provides live 3D HD view of the surgical field in robotic surgery operating room. The company is based in Fort Lauderdale, Florida.